Molecular basis of allergic diseases

Molecular Genetics and Metabolism

Volumn 63, Issue 3, 1998, Pages 157-167

  Leung, Donald Y M ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Asthma; Atopic dermatitis; Cytokines; Eosinophils; T cells

Indexed keywords

BETA1 INTEGRIN; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EOTAXIN; GAMMA INTERFERON; GLUCOCORTICOID; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; RANTES; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ASTHMA; ATOPIC DERMATITIS; CHROMOSOME 5Q; CORTICOSTEROID THERAPY; EOSINOPHIL; GENOTYPE; HELPER CELL; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INFLAMMATORY DISEASE; MAST CELL; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE;

EID: 0031695898     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1998.2682     Document Type: Article

References (91)

1. Schultz Larsen F, Diepgen T, Svensson A. The occurrence of atopic dermatitis in north Europe: An international questionnaire study. J Am Acad Dermatol 34:760-764, 1996.
2. Centers for Disease Control and Prevention. Asthma mortality and hospitalization among children and young adults -United States, 1990-1993. MMWR 45:350-353, 1996.
3. Mudde GC, Van Reijsen FC, Boland GJ, DeGast GC, Bruijnzeel PLB, Bruijnzeel-Koomen CAFM. Allergen presentation by epidermal Langerhans cells from patients with atopic dermatitis is mediated by IgE. Immunology 69:335-341, 1990.
4. Leung DYM. Role of IgE in atopic dermatitis. Curr Opin Immunol 5:956-962, 1993.
5. Dolovich J, Hargreave FE, Chalmers R, Shier KJ, Gauldie J, Bienenstock J. Late cutaneous allergic responses in isolated IgE-dependent reactions. J Allergy Clin Immunol 52:38-46, 1973.
6. Kay AM, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, Wardlaw AJ, Hamid Q. Messenger RNA expression of cytokine gene cluster, interleukin 3 (IL-3), IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 173:775-778, 1991.
7. Cartier A, Thomson N, Frith P, Roberts R, Hargreave F. Allergen-induced increase in bronchial responsiveness to histamine: Relationship to the late asthmatic response and change in airway caliber. J Allergy Clin Immunol 70:170-177, 1982.
8. Warner JO, Price J, Soothill J, Hey E. Controlled trial of hyposensitization with Dermatophagoides pteronyssinus antigen in children with asthma. Lancet 2:912-917, 1978.
9. Sur S, Crotty, TB, Kephart GM. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis 148:713-719, 1993.
10. Wenzel SE, Szefler SJ, Leung DYM, Sloan S, Rex M, Martin RJ. Bronchoscopic evaluation of severe asthma: persistent inflammation despite high dose glucocorticoids. Am J Respir Crit Care Med 156:734-774, 1997.
11. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 87:893-910, 1991.
12. Weller P. Cytokine regulation of eosinophil function. Curr Immunol Immunopathol 62:55-59, 1992.
13. H2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326:298-304, 1992.
14. Hamid Q, Boguniewicz M, Leung DYM. Differential in situ cytokine gene expression in acute vs. chronic atopic dermatitis. J Clin Invest 94:870-876, 1994.
15. Bochner BS, Schleimer RP. The role of adhesion molecules in human eosinooophil and basophil recruitment. J Allergy Clin Immunol 94:427-438, 1994.
16. Weller P, Rand T, Goelz S, Chi-Rosso G, Lobb R. Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell ashesion molecule-1 and endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 88:7430-7433, 1991.
17. Alam R. Chemokines in allergic inflammation. J Allergy Clin Immunol 94:427-438, 1994.
18. Montefort S, Roche WR, Howart PH, Djukanovic R, Gratziou C, Carroll M, Smith L, Britten KM, Haskard D, Lee TH, Holgate ST. Intercellular adhesion molecule-1 (ICAM-1) and endothelial leukocyte adhesion molecule-1. Eur Respir J 5:815-823, 1992.
19. Groves RW, Allen MH, Haskard DO, MacDonald DM. Endothelial leukocyte adhesion molecule-1 in acute and chronic eczema: In Immunological and Pharmacological Aspects of Atopic and Contact Eczema (Czernielewski JM, Ed.). Basel: Karger, 1991, pp 85-88.
20. Kyan-Aung U, D H, Poston R, Thornhill M, Lee T. Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cell in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J Immunol 146:521-528, 1991.
21. Leung DYM, Cotran RS, Pober JS. Expression of an endothelial leukocyte adhesion molecule (ELAM-1) in elicited late phase allergic skin reactions. J Clin Invest 87:1805-1810, 1991.
22. Bittleman D, Casale T. Allergic models and cytokines. Am J Respir Crit Care Med 150:872-876, 1994.
23. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 154:799-803, 1995.
24. Walsh G, Mermod J, Harnell A, Kay A, Wardlaw A. Human eosinopohil, but not neutrophil, adherence to IL-1-stimulated human umbilical vascular endothelial cells is alpha 4 beta 1 (very late antigen-4) dependent. J Immunol 146:3419-3423, 1991.
25. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ. A new class of membrane-bound chemokine with a CX3C motif. Nature 385:640-644, 1997.
26. Stellato C, Collins P, Ponath P, Soler D, Newman W, La Rosa G, Haodong L, White J, Schwiebert L, Bickel C, Liu M, Bochner B, Williams T, Schleimer R. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J Clin Invest 99:926-936, 1997.
27. Heath H, Shixin Q, Rao P, Wu L, LaRosa G, Kassam N, Ponath P, Mackay C. Chemokine receptor usage by human eosinophils. J Clin Invest 99:178-184, 1997.
28. Sedar R, Paul W. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 12:635-673, 1994.
29. Gascan H, Gauchet J-F, Roncarolo M-G, Yssel H, Spits H, de Vries JE. Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones. J Exp Med 173:747-750, 1991.
30. De Vries J. Novel fundamental approaches to intervening in IgE-mediated allergic diseases. J Invest Dermatol 102:141-144, 1994.
31. Tsuyuki S, Tsuyuki J, Einsle K, Kop M, Coyle A. Costimulation through B7.2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (Th2) immune response and altered airway hyperesponsiveness. J Exp Med 185:1671-1679, 1997.
32. Hofer M, Jirapongsananuruk O, Trumble A, Leung DYM. B7.2, but not B7.1, is upregulated on B cells from patients with allergic asthma exposed to allergens and its expression is modulated by IL-4 and IL-13. J Allergy Clin Immunol, in press.
33. Jirapongsananuruk O, Hofer MF, Trumble AE, Norris DA, Leung, DYM. Enhanced expression of B7.2 (CD86) in patients with atopic dermatitis: A potential role in the modulation of IgE synthesis. J Allergy Clin Immunol, in press.
34. Jujo K, Renz H, Abe J, Gelfand EW, Leung DYM. Decreased gamma interferon and increased interleukin-4 production promote IgE synthesis in atopic dermatitis. J Allergy Clin Immunol 90:323-330, 1992.
35. Renz H, Jujo K, Bradley K, Domenico J, Gelfand EW, Leung DYM. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and IL-4 recpetor expression in atopic dermatitis and their modulation by interferon-gamma. J Invest Dermatol 99:403-408, 1992.
36. H2 murine helper T lymphocyte clones using IL-2 and reominant IFN-γ. J Immunol 143:15-22, 1989.
37. H-2 cells. Int Arch Allergy Immunol 113:153-156, 1997.
38. H-2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 23:1445-1449, 1993.
39. H2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 90:184-193, 1992.
40. Naseer T, Minshall E, Laberge S, Ernst P, Martin R, Leung DYM, Hamid Q. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 155:845-851, 1997.
41. Hamid Q, Naseer T, Minshall Em, Song TL, Boguniewicz M, Leung DYM. In vivo expression of interleukin-12 and interleukin-13 in atopic dermatitis. J Allergy Clin Immunol 98:225-231, 1996.
42. H2 cells. J Immunol 148:3820-3829, 1992.
43. Manetti R, Parronchi P, Giudizi MG, Piccinni M, Maggi E, Trinchieri G, Romagnani S. Natural killer cell stimulatory factor (interleukin-12 [IL-12]) induces T helper type 1 (Th1) specific immune responses and inhibits the development of IL-4 producing T cells. J Exp Med 177:1199-1204, 1993.
44. Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky D, Gubler U, Sinigaglia F. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 185:825-831, 1997.
45. Shirakawa T, Enomoto T, Shimazu S-I, Hopkin J. The inverse association between tuberculin responses and atopic disorder. Science 275:77-79, 1997.
46. Leung DYM, Picker L. Adhesion pathways controlling recruitment responses of lymphocytes during allergic inflammatory reactions in vivo. In Adhesion Molecules in Allergic Disease (Bochner B, Ed.). New York: Marcel Dekker, 1997, pp 294-314.
47. Butcher E, Picker L. Lymphocyte homing and homeostasis. Science 272:60-66, 1996.
48. Picker L, Martin R, Trumble A, Newman L, Collins P, Bergstresser P, Leung DYM. Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites. Eur J Immunol 24:1269-1277, 1994.
49. Abernathy-Carver KJ, Sampson HA, Picker LJ, Leung DYM. Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen. J Clin Invest 95:913-918, 1995.
50. Santamaria Babi LF, Picker LJ, Perez Soler MT, Drzimalla K, Flohr P, Blaser K, Hauser C. Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J Exp Med 181:1935-1940, 1995.
51. Leung DYM, Gately M, Trumble A, Ferguson-Darnell B, Schlievert P, Picker L. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med 181:747-753, 1995.
52. Leung DYM, Harbeck R, Bina P, Hanifin J, Reiser R, Sampson H. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis: Evidence for a new group of allergens. J Clin Invest 92:1374-1380, 1993.
53. Jones SM, Sampson HA. The role of allergens in atopic dermatitis. In Atopic Dermatitis: From Pathogenesis to Treatment (Leung DYM, Ed.). Austin, TX: R. G. Landes Co., 1996, pp 41-66.
54. Chan SC, Kim JW, Henderson WR, Hanifin JM. Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis. J Immunol 151:3345-3352, 1993.
55. Lester MR, Gately M, Trumble A, Leung DYM. Effects of IL-12 and staphylococcal toxic shock syndrome toxin-1 on the interferon-gamma response in atopic dermatitis. J Immunol 95:913-918, 1995.
56. Matsumoto K, Schleimer RP, Saito H, Iikura Y, Bochner BS. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 86:1437-1443, 1995.
57. Yang E, Zha J, Jockel J, Boise L, Thompson C, Korsmeyer S. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80:285-291, 1995.
58. Enari M, Hug H, Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375:78-81, 1995.
59. Suzuki S, Okubo M, Kaise S, Ohara M, Kasukawa R. Gold sodium thiomalate selectivity inhibits interleukin-5 mediated eosinophil survival. J Allergy Clin Immunol 96:251-256, 1995.
60. Bratton DL, Hamid Q, Boguniewicz M, Doherty DE, Kailey JM, Leung DYM. Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis. J Clin Invest 95:211-218, 1995.
61. Woolley K, Gibson P, Carty K, Wilson A, Twaddell S, Woolley M. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med 154:237-243, 1996.
62. Nimmigadda SR, Szefler SJ, Surs W, Spahn JD, Leung DYM. Allergen exposure decreases glucocorticoid receptor binding affinity and steroid responsiveness in atopic asthmatics. Am J Respir Cell Mol Biol 155:87-93, 1997.
63. Clayton MH, Leung DYM, Suyrs W, Szefler SJ. Altered glucocorticoid receptor binding in atopic dermatitis. J Allergy Clin Immunol. 96:421-423, 1996.
64. Herrscher RF, Kasper C, Sullivan TJ. Endogenous cortisol regulates immunoglobulin E-dependent late phase reaction. J Clin Invest 90:596-603, 1992.
65. Duffy DL, Martin NG, Battistutt D, Hopper JL, Mathews JD. Genetics of asthma and hay fever in Australian twins. Am Rev Respir Dis 142:1351-1358, 1990.
66. Holgate ST. Asthma genetics: Waiting to exhale. Nature Genet. 15:227-229, 1997.
67. Moffatt MF, Hill MR, Cornelis F, Schou C, Faux JA, Young RP, James AL, Ryan G, Le Souef P, Musk AW. Genetic linkage of T cell receptor a/d complex to specific IgE responses. Lancet 343:1597-1600, 1994.
68. Marsh DG, Neely J, Breazeale R, Ghosh B, Friedhoff LR, Schou C, Beaty TH. Total serum IgE levels and chromosoem 5q. Clin Exp Allergy 25:79-83, 1995.
69. Marsh D, Neely JD, Breazeale D, Ghosh B, Freidhoff LR, Ehrlich-Kautzky E, Schou C, Krishnaswamy G, Beaty TH. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum IgE concentrations. Science 264:1152-1156, 1994.
70. Postma DS, Bleecker ER, Amelung PJ, Holroyd KJ, Xu J, Panhuysen CI, Meyers DA, Levitt RC. Genetic susceptibility to asthma: Bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 333:894-900, 1995.
71. Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M, Borish L. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 25:74-78; discussion, 75-76, 1995.
72. Reihsaus E, Innis M, MacIntyre N, Liggett SB. Mutations in the gene encoding for the β2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 8:334-339, 1993.
73. 2-adrenergic receptor in nocturnal and non-nocturnal asthma: Evidence that Gly 16 correlates with the nocturnal phenotype. J Clin Invest 95:1635-1641, 1995.
74. 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 345:1213-1214, 1995.
75. Walker KB, Potter JM, House AK. Interleukin 2 synthesis in the presence of steroid: a model of steroid resistance. Clin Exp Immunol 68:162-167, 1987.
76. Leung DYM. The glucocorticoid receptor as a target in the pathogenesis of steroid resistant asthma. In Severe Asthma: Pathogenesis and Management (Szefler SJ, Leung DYM, Eds.). New York: Marcel Dekker, 1995, pp 283-312.
77. Lee T, Brattsand R, Leung DYM. Corticosteroid action and resistance in asthma. Am J Respir Cell Mol Biol 154:S1-S79, 1996.
78. Alvarez J, Surs W, Leung DYM, Iklé D, Gelfand EW, Szefler SJ. Steroid-resistant asthma: Immunologic and pharmacologic features. J Allergy Clin Immunol 89:714-721, 1992.
79. Corrigan CJ, Brown PH, Barnes NC, Tsai J-J, Frew AJ, Kay AB. Glucocorticoid resistance in chronic asthma: Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am Rev Respir Dis 144:1026-1032, 1991.
80. Munck A, Mendel DB, Smith LI, Orti E. Glucocorticoid receptors and actions. Am Rev Respir Dis 141:S2-S10, 1990.
81. Sher ER, Leung DYM, Surs W, Kam JC, Zieg G, Kamada AK, Harbeck R, Szefler SJ. Steroid resistant asthma: Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 93:33-39, 1994.
82. Kam JC, Szefler SJ, Surs W, Sher ER, Leung DYM. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 151:3460-3466, 1993.
83. Leung DYM, Martin RJ, Szefler SJ, Sher ER, Ying S, Ming Q, Kay AB, Hamid Q. The airways of steroid resistant vs steroid sensitive asthma are associated with different patterns of cytokine gene expression. J Exp Med 181:33-40, 1995.
84. Bamberger CM, Bamberger AM, de Castro M, Chrousos GP. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95:2435-2441, 1995.
85. Leung DYM, Hamid Q, Vottero A, Szefler SJ, Surs W, Minshall E, Chrousos GP, Klemm D. Association of glucocortioid insensitivity with increased expression of glucocorticoid receptor β. J Exp Med 186:1567-1574, 1997.
86. Sears MR, Herbison GP, Holdaway MD, Hewitt CJ, Flannery EM, Silva PA. The relative risk of sensitivity to grass pollen, house dust mite and cat dander in the development of childhood asthma. Clin Exp Allergy 19:419-442, 1989.
87. Schwartz J, Slater D, Larson T, Pierson W, Koenig J. Particulate air pollution and hospital emergency room visits for asthma in Seattle. Am Rev Respir Dis 147:826-831, 1993.
88. Haahtela T, Jarvinen M, Kava T. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 331:700-705, 1994.
89. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 88:373-381, 1994.
90. 1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 17:326-333, 1997.
91. Corne J, Djukanovic R, Thomas L, Warner J, Botta L, Grandordy B, Gygax D, Heusser C, Patalano F, Richardson W, Kilchherr E, Staehelin T, Davis F, Gordon W, Sun L, Liou R, Wang G, Chang T, Holgate ST. The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: Efficacy, safety and pharmacokinetics. J Clin Invest 99:879-887, 1997.